Annual EBITDA:
$476.12M+$112.97M(+31.11%)Summary
- As of today, MEDP annual EBITDA is $476.12 million, with the most recent change of +$112.97 million (+31.11%) on December 31, 2024.
- During the last 3 years, MEDP annual EBITDA has risen by +$240.10 million (+101.73%).
- MEDP annual EBITDA is now at all-time high.
Performance
MEDP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$148.86M+$15.51M(+11.63%)Summary
- As of today, MEDP quarterly EBITDA is $148.86 million, with the most recent change of +$15.51 million (+11.63%) on September 30, 2025.
- Over the past year, MEDP quarterly EBITDA has increased by +$29.07 million (+24.26%).
- MEDP quarterly EBITDA is now at all-time high.
Performance
MEDP Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$535.54M+$29.07M(+5.74%)Summary
- As of today, MEDP TTM EBITDA is $535.54 million, with the most recent change of +$29.07 million (+5.74%) on September 30, 2025.
- Over the past year, MEDP TTM EBITDA has increased by +$98.01 million (+22.40%).
- MEDP TTM EBITDA is now at all-time high.
Performance
MEDP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
MEDP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +31.1% | +24.3% | +22.4% |
| 3Y3 Years | +101.7% | +68.9% | +80.4% |
| 5Y5 Years | +216.5% | +170.4% | +201.7% |
MEDP EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +101.7% | at high | +71.3% | at high | +80.4% |
| 5Y | 5-Year | at high | +216.5% | at high | +188.1% | at high | +201.7% |
| All-Time | All-Time | at high | +432.7% | at high | +1376.6% | at high | +5212.4% |
MEDP EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $148.86M(+11.6%) | $535.54M(+5.7%) |
| Jun 2025 | - | $133.35M(+10.7%) | $506.48M(+4.3%) |
| Mar 2025 | - | $120.45M(-9.4%) | $485.51M(+2.0%) |
| Dec 2024 | $476.12M(+31.1%) | $132.88M(+10.9%) | $476.12M(+8.8%) |
| Sep 2024 | - | $119.79M(+6.6%) | $437.53M(+6.8%) |
| Jun 2024 | - | $112.39M(+1.2%) | $409.52M(+5.8%) |
| Mar 2024 | - | $111.06M(+17.8%) | $386.95M(+3.8%) |
| Dec 2023 | $363.15M(+13.8%) | $94.29M(+2.7%) | $372.81M(+2.0%) |
| Sep 2023 | - | $91.79M(+2.2%) | $365.40M(+1.0%) |
| Jun 2023 | - | $89.81M(-7.3%) | $361.74M(+5.7%) |
| Mar 2023 | - | $96.92M(+11.5%) | $342.12M(+7.2%) |
| Dec 2022 | $319.05M(+35.2%) | $86.89M(-1.4%) | $319.05M(+7.5%) |
| Sep 2022 | - | $88.12M(+25.5%) | $296.90M(+9.2%) |
| Jun 2022 | - | $70.20M(-4.9%) | $271.81M(+7.3%) |
| Mar 2022 | - | $73.85M(+14.1%) | $253.28M(+7.3%) |
| Dec 2021 | $236.02M(+17.7%) | $64.73M(+2.7%) | $236.02M(+0.1%) |
| Sep 2021 | - | $63.03M(+22.0%) | $235.72M(+3.5%) |
| Jun 2021 | - | $51.67M(-8.7%) | $227.74M(+6.3%) |
| Mar 2021 | - | $56.59M(-12.2%) | $214.22M(+6.8%) |
| Dec 2020 | $200.49M(+33.3%) | $64.43M(+17.0%) | $200.49M(+13.0%) |
| Sep 2020 | - | $55.04M(+44.3%) | $177.50M(+12.7%) |
| Jun 2020 | - | $38.15M(-11.0%) | $157.51M(-1.3%) |
| Mar 2020 | - | $42.87M(+3.5%) | $159.59M(+6.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | $150.45M(+7.6%) | $41.44M(+18.2%) | $150.45M(+0.7%) |
| Sep 2019 | - | $35.05M(-12.9%) | $149.43M(-1.1%) |
| Jun 2019 | - | $40.24M(+19.3%) | $151.03M(+5.1%) |
| Mar 2019 | - | $33.73M(-16.5%) | $143.75M(+2.8%) |
| Dec 2018 | $139.85M(+25.6%) | $40.41M(+10.3%) | $139.85M(+10.6%) |
| Sep 2018 | - | $36.65M(+11.2%) | $126.47M(+6.5%) |
| Jun 2018 | - | $32.96M(+10.5%) | $118.75M(+4.5%) |
| Mar 2018 | - | $29.82M(+10.3%) | $113.63M(+2.1%) |
| Dec 2017 | $111.33M(+0.7%) | $27.04M(-6.5%) | $111.33M(-0.4%) |
| Sep 2017 | - | $28.93M(+3.9%) | $111.81M(+1.6%) |
| Jun 2017 | - | $27.84M(+1.2%) | $110.08M(-0.7%) |
| Mar 2017 | - | $27.52M(+0.0%) | $110.82M(+0.2%) |
| Dec 2016 | $110.60M(+11.3%) | $27.52M(+1.2%) | $110.60M(+33.1%) |
| Sep 2016 | - | $27.20M(-4.8%) | $83.08M(+3.3%) |
| Jun 2016 | - | $28.57M(+4.6%) | $80.47M(+2.7%) |
| Mar 2016 | - | $27.31M(+11.1%) | $78.33M(+4.2%) |
| Dec 2015 | $99.40M(+5.7%) | - | - |
| Sep 2015 | - | $24.58M(-7.0%) | $75.21M(+48.5%) |
| Jun 2015 | - | $26.44M(+9.3%) | $50.63M(+109.3%) |
| Mar 2015 | - | $24.19M(+139.9%) | $24.19M(+139.9%) |
| Dec 2014 | $94.06M(+5.2%) | - | - |
| Mar 2014 | - | $10.08M | $10.08M |
| Dec 2013 | $89.38M | - | - |
FAQ
- What is Medpace Holdings, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Medpace Holdings, Inc.?
- What is Medpace Holdings, Inc. annual EBITDA year-on-year change?
- What is Medpace Holdings, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Medpace Holdings, Inc.?
- What is Medpace Holdings, Inc. quarterly EBITDA year-on-year change?
- What is Medpace Holdings, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Medpace Holdings, Inc.?
- What is Medpace Holdings, Inc. TTM EBITDA year-on-year change?
What is Medpace Holdings, Inc. annual EBITDA?
The current annual EBITDA of MEDP is $476.12M
What is the all-time high annual EBITDA for Medpace Holdings, Inc.?
Medpace Holdings, Inc. all-time high annual EBITDA is $476.12M
What is Medpace Holdings, Inc. annual EBITDA year-on-year change?
Over the past year, MEDP annual EBITDA has changed by +$112.97M (+31.11%)
What is Medpace Holdings, Inc. quarterly EBITDA?
The current quarterly EBITDA of MEDP is $148.86M
What is the all-time high quarterly EBITDA for Medpace Holdings, Inc.?
Medpace Holdings, Inc. all-time high quarterly EBITDA is $148.86M
What is Medpace Holdings, Inc. quarterly EBITDA year-on-year change?
Over the past year, MEDP quarterly EBITDA has changed by +$29.07M (+24.26%)
What is Medpace Holdings, Inc. TTM EBITDA?
The current TTM EBITDA of MEDP is $535.54M
What is the all-time high TTM EBITDA for Medpace Holdings, Inc.?
Medpace Holdings, Inc. all-time high TTM EBITDA is $535.54M
What is Medpace Holdings, Inc. TTM EBITDA year-on-year change?
Over the past year, MEDP TTM EBITDA has changed by +$98.01M (+22.40%)